Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patients

An Introduction to the Bootstrap

1993 • 19,341 citations

Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

2000 • 3,258 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 1,908 citations

THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY

1989 • 1,387 citations

Relapses and Progression of Disability in Multiple Sclerosis

2000 • 1,285 citations

The natural history of multiple sclerosis:a geographically based study

1999 • 1,190 citations

Statistics with Confidence

2000 • 746 citations

THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY

1989 • 597 citations

THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY

1991 • 409 citations

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-?1a in relapsing-remitting multiple sclerosis

1999 • 384 citations

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

1998 • 334 citations

Defining interferon β response status in multiple sclerosis patients

2004 • 216 citations

TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis

2003 • 205 citations

Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods

2004 • 175 citations

THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY

1991 • 172 citations

Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis

2003 • 170 citations

Neutralizing antibodies reduce the efficacy of βIFN during treatment of multiple sclerosis

2004 • 153 citations

Final analysis of the European multicenter trial on IFNβ-1b in secondary-progressive MS

2001 • 139 citations

Assessment of different treatment failure criteria in a cohort of relapsing–remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

2002 • 125 citations

HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis

2001 • 82 citations

Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS

2000 • 67 citations

Meta-analysis of the placebo-treated groups in clinical trials of progressive MS

1996 • 64 citations

Identifying and treating patients with suboptimal responses

2004 • 56 citations

Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis

2004 • 49 citations

Steroid Correlates of Territorial Behavior in Male Jacky Dragons, <i>Amphibolurus muricatus</i>

2003 • 45 citations

Clinical characteristics of responders to interferon therapy for relapsing MS

2004 • 27 citations

Long-Term Follow-Up of Childhood-Onset Hypopituitarism in Patients with the PROP-1 Gene Mutation

2003 • 24 citations

Lipoprotein Lipase Activity and Common Gene Variants in Severely Hypertriglyceridemic Patients with and without Diabetes

2003 • 7 citations